This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US
September 23-26, 2024
Hynes Convention CenterBoston, MA

Marinna Madrid
Co-Founder & Chief Product Officer at Cellino


Marinna Madrid, Ph.D., is Co-Founder & Chief Product Officer at Cellino. She is a 2019 Forbes 30 under 30 awardee for healthcare. She has several patents & peer-reviewed publications and wrote the first review paper on autologous induced pluripotent stem cell (iPSC)-based cell therapies. Marinna obtained her Ph.D. and MA in Applied Physics from Harvard University, where she co-invented laser-based intracellular delivery techniques.

Agenda Sessions

  • An autonomous Biomanufacturing platform to scale production of autologous iPSC-derived cell therapies